Bullous cutaneous reactions
Mohamed Jira, Taoufik Amezyane
Corresponding author: Mohamed Jira, Internal Medicine Department, Mohammed V Military Teaching Hospital, Rabat, Morocco
Received: 19 Jul 2018 - Accepted: 24 Sep 2018 - Published: 16 Nov 2018
Domain: Allergy and Immunology,Dermatology
Keywords: Allopurinol hypersensitivity, bullous cataneous reactions
©Mohamed Jira et al. Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cite this article: Mohamed Jira et al. Bullous cutaneous reactions. Pan African Medical Journal. 2018;31:188. [doi: 10.11604/pamj.2018.31.188.16608]
Available online at: https://www.panafrican-med-journal.com//content/article/31/188/full
Bullous cutaneous reactions
Mohamed Jira1,&, Taoufik Amezyane1
1Internal Medicine Department, Mohammed V Military Teaching Hospital, Rabat, Morocco
&Corresponding author
Mohamed Jira, Internal Medicine Department, Mohammed V Military Teaching Hospital,
Rabat, Morocco
Allopurinol (xanthine oxidase inhibitor) is indicated for the treatment of symptomatic hyperuricemia, the treatment of gout and the treatment and prevention of uric and calcium lithiasis. It is one of the leading drugs for severe toxic dermal reactions, such as Lyell Syndrome (NET), Stevens-Johnson Syndrome (SJS) and Dress Syndrome (Drug reaction with eosinophilia and systemic symptoms). We report the case of a 45-year-old woman who was hospitalized for bullous skin rashes, without pathological history, the patient had generalized erythematous and bullous rash (A, B and C) one week after taking allopurinol, prescribed by his rheumatologist for a gout. The diagnosis of bullous Cutaneous reaction due to allopurinol was retained, allopurinol was discontinued and the course was favorable with the disappearance of cutaneous lesions.
Figure 1: A) bullous cutaneous reaction of the hand; B) bullous cutaneous reaction of the leg; C) bullous cutaneous reaction of the foot